Literature DB >> 3547401

Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer.

J Sorge, W Kuhl, C West, E Beutler.   

Abstract

Glucocerebrosidase cDNA and the neomycin-resistance gene (neo) were cloned into a retrovirus vector. Mouse fibroblasts infected with this vector expressed human glucocerebrosidase, which was readily distinguished from the mouse enzyme using mouse monoclonal anti-glucocerebrosidase antibodies. Cultured fibroblasts and transformed lymphoblasts from patients with type I Gaucher disease were infected with the retrovirus rescued from the mouse fibroblasts by a helper virus. Transformed cells were selected with the antibiotic G418. The enzyme activity of cells infected with virus containing glucocerebrosidase cDNA was restored to normal, while uninfected cells or cells infected with virus containing only the neo gene did not produce glucocerebrosidase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3547401      PMCID: PMC304328          DOI: 10.1073/pnas.84.4.906

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease.

Authors:  C G Groth; H Collste; S Dreborg; G Håkansson; G Lundgren; L Svennerholm
Journal:  Transplant Proc       Date:  1979-06       Impact factor: 1.066

4.  Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.

Authors:  R O Brady; P G Pentchev; A E Gal; S R Hibbert; A S Dekaban
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

5.  Splenic transplantation in a case of Gaucher's disease.

Authors:  C G Groth; L Hagenfeldt; S Dreborg; B Löfström; P A Ockerman; K Samuelsson; L Svennerholm; B Werner; G Westberg
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

6.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

7.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

8.  Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase.

Authors:  G Gregoriadis; D Neerunjun; T W Meade; S K Goolamali; H Weereratne; G Bull
Journal:  Birth Defects Orig Artic Ser       Date:  1980

9.  Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.

Authors:  S S Raghavan; J Topol; E H Kolodny
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

10.  Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.

Authors:  E Beutler; W Kuhl; F Matsumoto; G Pangalis
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  16 in total

1.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

Review 3.  Gene transfer into the nervous system.

Authors:  X O Breakefield; A I Geller
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

4.  Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.

Authors:  P H Correll; J K Fink; R O Brady; L K Perry; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Bone marrow transplantation beyond treatment of aplasia and neoplasia.

Authors:  E Beutler
Journal:  West J Med       Date:  1994-02

Review 6.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library.

Authors:  B Y Wong; H Chen; S W Chung; P M Wong
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 8.  Alglucerase. A review of its therapeutic use in Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

9.  Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.

Authors:  J A Nolta; X J Yu; I Bahner; D B Kohn
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

10.  Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVs.

Authors:  F L Cosset; C Legras; J L Thomas; R M Molina; Y Chebloune; C Faure; V M Nigon; G Verdier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.